ZIPK activates the IL‐6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells

Gastric cancer is one of the most common malignant cancers globally. Chemotherapy resistance remains a major obstacle in the treatment of gastric cancer, and the molecular mechanisms underlying drug resistance are still not well understood. We previously reported that Zipper interacting protein kina...

Full description

Bibliographic Details
Main Authors: Haonan Fan, Qifeng Ou, Qiao Su, Guanman Li, Zhijuan Deng, Xiaohui Huang, Jiong Bi
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:FEBS Open Bio
Subjects:
Online Access:https://doi.org/10.1002/2211-5463.13270
_version_ 1818574645558771712
author Haonan Fan
Qifeng Ou
Qiao Su
Guanman Li
Zhijuan Deng
Xiaohui Huang
Jiong Bi
author_facet Haonan Fan
Qifeng Ou
Qiao Su
Guanman Li
Zhijuan Deng
Xiaohui Huang
Jiong Bi
author_sort Haonan Fan
collection DOAJ
description Gastric cancer is one of the most common malignant cancers globally. Chemotherapy resistance remains a major obstacle in the treatment of gastric cancer, and the molecular mechanisms underlying drug resistance are still not well understood. We previously reported that Zipper interacting protein kinase (ZIPK), also known as death‐associated protein kinase3, exerts an oncogenic effect on gastric cancer via activation of Akt/NF‐κB signaling and promotion of stemness. Here, we explored the roles of ZIPK in cisplatin resistance. We report that ZIPK enhances cell proliferation and invasion and reduces the antitumor activity of cisplatin in gastric cancer. In addition, our western blot data suggest that ZIPK activated the IL‐6/STAT3 signaling pathway. Furthermore, ZIPK increased the expression of IL‐6 and multidrug‐resistance genes. Using the STAT3 inhibitor stattic to block the IL‐6/STAT3 signaling pathway strongly increased the sensitivity of ZIPK‐expressed cells to cisplatin. In conclusion, ZIPK may play a role in cisplatin resistance through activation of the IL‐6/ STAT3 signaling pathway. Inhibition of STAT3 in gastric cancer overexpressing ZIPK might have potential to improve the efficacy of cisplatin.
first_indexed 2024-12-15T00:29:18Z
format Article
id doaj.art-1d63c9ddcab347cd953ce67dd929a2bf
institution Directory Open Access Journal
issn 2211-5463
language English
last_indexed 2024-12-15T00:29:18Z
publishDate 2021-09-01
publisher Wiley
record_format Article
series FEBS Open Bio
spelling doaj.art-1d63c9ddcab347cd953ce67dd929a2bf2022-12-21T22:42:04ZengWileyFEBS Open Bio2211-54632021-09-011192655266710.1002/2211-5463.13270ZIPK activates the IL‐6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cellsHaonan Fan0Qifeng Ou1Qiao Su2Guanman Li3Zhijuan Deng4Xiaohui Huang5Jiong Bi6Laboratory of General Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou ChinaLaboratory of General Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou ChinaLaboratory Animal Center The First Affiliated Hospital Sun Yat‐sen University Guangzhou ChinaLaboratory of General Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou ChinaLaboratory of General Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou ChinaLaboratory of General Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou ChinaLaboratory of General Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou ChinaGastric cancer is one of the most common malignant cancers globally. Chemotherapy resistance remains a major obstacle in the treatment of gastric cancer, and the molecular mechanisms underlying drug resistance are still not well understood. We previously reported that Zipper interacting protein kinase (ZIPK), also known as death‐associated protein kinase3, exerts an oncogenic effect on gastric cancer via activation of Akt/NF‐κB signaling and promotion of stemness. Here, we explored the roles of ZIPK in cisplatin resistance. We report that ZIPK enhances cell proliferation and invasion and reduces the antitumor activity of cisplatin in gastric cancer. In addition, our western blot data suggest that ZIPK activated the IL‐6/STAT3 signaling pathway. Furthermore, ZIPK increased the expression of IL‐6 and multidrug‐resistance genes. Using the STAT3 inhibitor stattic to block the IL‐6/STAT3 signaling pathway strongly increased the sensitivity of ZIPK‐expressed cells to cisplatin. In conclusion, ZIPK may play a role in cisplatin resistance through activation of the IL‐6/ STAT3 signaling pathway. Inhibition of STAT3 in gastric cancer overexpressing ZIPK might have potential to improve the efficacy of cisplatin.https://doi.org/10.1002/2211-5463.13270chemotherapy resistancegastric cancerzipper interacting protein kinaseIL‐6/STAT3 signaling pathway
spellingShingle Haonan Fan
Qifeng Ou
Qiao Su
Guanman Li
Zhijuan Deng
Xiaohui Huang
Jiong Bi
ZIPK activates the IL‐6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells
FEBS Open Bio
chemotherapy resistance
gastric cancer
zipper interacting protein kinase
IL‐6/STAT3 signaling pathway
title ZIPK activates the IL‐6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells
title_full ZIPK activates the IL‐6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells
title_fullStr ZIPK activates the IL‐6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells
title_full_unstemmed ZIPK activates the IL‐6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells
title_short ZIPK activates the IL‐6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells
title_sort zipk activates the il 6 stat3 signaling pathway and promotes cisplatin resistance in gastric cancer cells
topic chemotherapy resistance
gastric cancer
zipper interacting protein kinase
IL‐6/STAT3 signaling pathway
url https://doi.org/10.1002/2211-5463.13270
work_keys_str_mv AT haonanfan zipkactivatestheil6stat3signalingpathwayandpromotescisplatinresistanceingastriccancercells
AT qifengou zipkactivatestheil6stat3signalingpathwayandpromotescisplatinresistanceingastriccancercells
AT qiaosu zipkactivatestheil6stat3signalingpathwayandpromotescisplatinresistanceingastriccancercells
AT guanmanli zipkactivatestheil6stat3signalingpathwayandpromotescisplatinresistanceingastriccancercells
AT zhijuandeng zipkactivatestheil6stat3signalingpathwayandpromotescisplatinresistanceingastriccancercells
AT xiaohuihuang zipkactivatestheil6stat3signalingpathwayandpromotescisplatinresistanceingastriccancercells
AT jiongbi zipkactivatestheil6stat3signalingpathwayandpromotescisplatinresistanceingastriccancercells